# Time to Initiated Antitumor Therapy for Tumor Patients With COVID19 Infection

> **NCT06006845** · — · UNKNOWN · sponsor: **The Seventh Affiliated Hospital of Sun Yat-sen University** · enrollment: 100 (estimated)

## Conditions studied

- Tumor
- COVID-19

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06006845
- **Lead sponsor:** The Seventh Affiliated Hospital of Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-12-01
- **Primary completion:** 2023-02-01
- **Final completion:** 2024-08-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2023-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06006845

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06006845, "Time to Initiated Antitumor Therapy for Tumor Patients With COVID19 Infection". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06006845. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*